News Daily News VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks Michael O'Riordan September 24, 2020
News Conference News CRT 2020 AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3 L.A. McKeown February 27, 2020
News Daily News ‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues Todd Neale June 24, 2019
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Conference News TCT 2018 RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation Todd Neale September 26, 2018
News Conference News TCT 2018 Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation Todd Neale September 25, 2018
News Conference News EuroPCR 2018 Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension Michael O'Riordan May 23, 2018
News Industry News Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension April 09, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Daily News Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR Shelley Wood October 16, 2017
News Daily News No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis Shelley Wood March 06, 2017
News Daily News Calculator Developed to Predict AKI Risk After Angiography in VA Population Caitlin E. Cox December 29, 2015
News Daily News Hemodynamic Guidance of Hydration Cuts Contrast Nephropathy in Patients With Kidney Disease, Heart Failure Todd Neale December 09, 2015
News Daily News El Guiado Hemodinámico de la Hidratación Reduce la Nefropatía por Contraste en Pacientes con Enfermedad Renal, Insuficiencia Cardíaca Todd Neale December 09, 2015
Presentation Prevention of Contrast-Induced Nephropathy by Central Venous Pressure (CVP)-Guided Fluid Administration Presenter: G. Qian December 08, 2015
News Daily News More Than Half of CVD Studies Exclude Patients With Kidney Disease Michael O'Riordan December 03, 2015
News Daily News RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline September 22, 2015
News Industry News Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure August 31, 2015